来自西班牙的COVID-19患者的抗血栓使用模式:现实世界数据研究
Karen Lizzette Ramirez-Cervantes1, Salvador Campillo-Morales2, Patricia García-Poza3
1Spanish Association Against Cancer, Division of Cancer Prevention, C/Teniente Coronel Noreña 30, 28045 Madrid, Spain.
Journal of clinical medicine
|April 27, 2024
概括
这项研究分析了西班牙COVID-19患者的抗血栓使用情况. 调查结果显示,尽管在治疗COVID-19相关血栓形成方面存在共识,但医院处方率较低.
科学领域:
- 心脏病学 心脏病学
- 流行病学 流行病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗血栓剂对于管理COVID-19相关的血栓形成至关重要.
- 在COVID-19中使用抗血栓剂的人口水平研究有限.
- 了解处方模式对于优化患者护理至关重要.
研究的目的:
- 描述西班牙初级保健和住院COVID-19患者的抗血栓药物处方模式.
- 分析COVID-19诊断前后使用抗血栓剂的情况.
- 为了调查出院后的抗血栓使用.
主要方法:
- 使用BIFAP的电子健康记录进行现实数据研究.
- 在COVID-19诊断后±14天内对抗血栓药物处方的分析 (2020年3月至2022年2月).
- 用户被分为前期和新/原始类别,并对排放后的使用进行分析.
主要成果:
- 抗血栓剂被处方给4.6%的初级保健患者和53.6%的住院患者.
- 埃诺沙巴林在医院最常见;在初级保健中,乙盐酸最常见.
- 医院抗血栓使用率较低 (53.6%),新用户的使用率高于先前使用埃诺沙巴林的用户.
结论:
- 对于在COVID-19患者处方抗血栓剂存在共识.
- 住院COVID-19患者的处方率特别低.
- 需要进一步的研究,以了解和改进这种人群中抗血栓剂的使用情况.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
687
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
687
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522


